The immune system distinguishes self from non-self during viral and bacterial pathogenesis or from altered self in the recognition of tumor antigens through a ligand/receptor system comprised, in part, by the class I and class II antigen presenting molecules. The long-term goal of these studies is to determine the structural basis of these immune functions. This proposal focuses on the amino-terminal domains of these MHC glycoproteins, which have been associated with antigen presentation, alloantigenicity and MHC restriction. Variant MHC genes will be constructed by site-directed mutagenesis and by overlap extension. They will be introduced into cell lines and mice by DNA mediated gene transfer, and the resulting gene products will be assessed for antigen presentation and immune recognition properties using cellular immune response assays. Among the issues being addressed are: (1) a hypothesis suggesting that the position of amino acid side chains in and around the putative antigen binding site determines whether they influence functional properties; (2) whether the beta-sheet and alpha-helices of the putative antigen binding site interact to determine antigenic specificities recognized by T cells; (3) whether the loop regions of the amino-terminal domain of class I molecules influence antigen presentation; (4) the nature of intramolecular interactions within the amino-terminal domain that determine ability of class I molecules to present antigens; (5) to establish an MHC-free, murine cell line for gene transfer experiments to study the conserved properties of class I molecules that determine their antigen presenting capabilities, and (6) recent hypotheses that suggest class II molecules contain amino-terminal domains organized in a manner similar to class I molecules.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI028320-03
Application #
3142754
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1990-04-01
Project End
1995-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Tallquist, M D; Weaver, A J; Pease, L R (1998) Degenerate recognition of alloantigenic peptides on a positive-selecting class I molecule. J Immunol 160:802-9
Tallquist, M D; Yun, T J; Pease, L R (1996) A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J Exp Med 184:1017-26
Vallejo, A N; Allen, K S; Pease, L R (1995) A common mutation in the hominoid class I A-locus IFN-responsive element results in the loss of enhancer activity. Int Immunol 7:853-9
Yun, T J; Tallquist, M D; Rohren, E M et al. (1994) Minor pocket B influences peptide binding, peptide presentation and alloantigenicity of H-2Kb. Int Immunol 6:1037-47
Pullen, J K; Tallquist, M D; Melvold, R W et al. (1994) Recognition of a single amino acid change on the surface of a major transplantation antigen is in the context of self peptide. J Immunol 152:3445-52
Pease, L R; Horton, R M; Pullen, J K et al. (1993) Amino acid changes in the peptide binding site have structural consequences at the surface of class I glycoproteins. J Immunol 150:3375-81
Cai, Z; Pease, L R (1992) Structural and functional analysis of three D/L-like class I molecules from H-2v: indications of an ancestral family of D/L genes. J Exp Med 175:583-96
Horton, R M; Loveland, B E; Parwani, A et al. (1991) Characterization of the spontaneous mutant H-2Kbm29 indicates that gene conversion in H-2 occurs at a higher frequency than detected by skin grafting. J Immunol 147:3180-4
Pullen, J K; Hunt, H D; Pease, L R (1991) Peptide interactions with the Kb antigen recognition site. J Immunol 146:2145-51